Brazil Invests R$60 Million to Boost Health Technology Innovation for SUS
Brazil commits a R$60 million investment to transform CNPEM into a national hub for health innovation, advancing technologies for the SUS.
- • The Ministry of Health will invest R$60 million in CNPEM to boost health innovation.
- • CNPEM will be transformed into the first national hub for radical health innovation.
- • The initiative aims to develop new pharmaceuticals, active ingredients, and medical equipment domestically.
- • Ministers emphasized Brazil's commitment to sovereignty in health technology production.
Key details
On October 24, 2025, Brazil's Ministry of Health and Ministry of Science, Technology, and Innovation (MCTI) announced a landmark investment of R$60 million to strengthen health technology innovation for the Unified Health System (SUS). This investment, formalized through an addendum signed by Ministers Luciana Santos and Alexandre Padilha, designates the Ministry of Health as a co-manager of the National Center for Energy and Materials Research (CNPEM).
The funding will be used to enhance CNPEM’s infrastructure and specialized human resources, enabling the center to become the first national hub dedicated to radical health innovation. This initiative aims to accelerate the development of new pharmaceuticals, active pharmaceutical ingredients (IFAs), and advanced medical equipment produced domestically. The goal is to increase public access to Brazilian-made medicines, vaccines, and healthcare products, thereby reinforcing Brazil’s commitment to public health and scientific progress.
The announcement was made during the launch of the Radical Health Innovation Initiative at Einstein Hospital in São Paulo during a meeting of the Executive Group of the Health Economic-Industrial Complex (Geceis). Minister Santos highlighted that the new management model will integrate existing policies and position Brazil as a leader in global pharmaceutical innovation. Minister Padilha emphasized the importance of national sovereignty in health technology, stating, "Brazil has the knowledge and tools necessary to invest in its future."
This partnership represents a strategic move to foster research in complex medical equipment and pharmaceutical development within Brazil. By leveraging CNPEM’s scientific infrastructure, the government aims to fast-track projects that will benefit the SUS, ensuring greater independence in health technology production and access to cutting-edge health products for the Brazilian population.
This article was synthesized and translated from native language sources to provide English-speaking readers with local perspectives.